NDC directory

Semaglutide

Semaglutide · Novo Nordisk A/S · INJECTION, SOLUTION

0420-9317DRUG FOR FURTHER PROCESSINGBulk ingredient
Product NDC
0420-9317
Generic name
Semaglutide
Labeler name
Novo Nordisk A/S
Finished
false
Listing expiration date
20271231
Marketing category
DRUG FOR FURTHER PROCESSING
Dosage form
INJECTION, SOLUTION
SPL ID
4c31afa8-0ec4-43a6-82c6-5ed3ed8ef9d6
Product type
DRUG FOR FURTHER PROCESSING
Marketing start date
20260428
Product ID
0420-9317_4c31afa8-0ec4-43a6-82c6-5ed3ed8ef9d6
Active ingredients
  1. Name
    SEMAGLUTIDE
    Strength
    1.7 mg/.75mL
Packaging
  1. Package NDC
    0420-9317-01
    Description
    1440 TRAY in 1 BOX (0420-9317-01) / 160 SYRINGE in 1 TRAY / .75 mL in 1 SYRINGE
    Marketing start date
    28-APR-26
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Join as a DoctorSell on MedGrid

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.